HEALTH OF WOMAN. 2015.8(104):82–84 

Some aspects of iron deficiency anemia in pregnant 

Albota A.

Maternity hospital № 1, Chernivtsi 

This work presents the results of research on the effectiveness of the medical treatment Sufer® in correction of iron deficiency anemia of pregnant women comparing to other groups of drugs. After using Sufer® condition of pregnant women significantly improved, it was confirmed objectively and by laboratory research. Medical treatment was well tolerated by pregnant and has no adverse effects on the fetus. 

Key words: iron deficiency anemia in pregnant, Sufer®, good tolerability, hematocrit, hemoglobin, blood picture improvement, increase hemoglobin. 

REFERENCES

1. Бурлев ВА, Коноводова ЕН, Мурашко ЛЕ, Сопоева ЖА. 2002. Коррекция железодефицитных состояний у беременных с гестозом. Пробл. репрод. 6:30–34.

2. Дворецкий ЛИ. 1997. Железодефицитные анемии. РМЖ. 5:1234–1242.

3. Ермоленко ВМ, Филатова НН. 2004. Физиология метаболизма железа. Анемия. 1:3–10.

4. Astor BC, Muntner P, Levin A et al. 2002. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988–1994). Arch. Intern. Med. 162(12):1401–1408. http://dx.doi.org/10.1001/archinte.162.12.1401

5. Beaufrere В, Bresson JL, Briend A et al. 1995. Iron and pregnancy. Arch. Pediatr. 1:1209–1218.

6. Conrad МЕ. 1998. Iron Overloading Disorders and Iron Regulation. Seminars in Hematol. – W.B. Saunders Company 1:1–4.

7. Cook JD, Skikne BS, Baynes RD. 1994. Iron deficiency: the global perspective. Adv. Exp. Med. Biol. 356:219–228. http://dx.doi.org/10.1007/978-1-4615-2554-7_24; PMid:7887226

8. The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (2000) IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am. J. Kidney Dis. 37(1 Suppl. 1):S182–S238.

9. Frewin R, Henson A, Provan D. 1997. Iron deficiency anaemia. BMJ. 314:360–363. http://dx.doi.org/10.1136/bmj.314.7077.360; PMid:9040336 PMCid:PMC2125872